Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Ann Neurol. 2020 Apr;87(4):584-598. doi: 10.1002/ana.25687. Epub 2020 Feb 12.
Rapid eye movement sleep behavior disorder (RBD) is a prodromal synucleinopathy, as >80% will eventually convert to overt synucleinopathy. We performed an in-depth analysis of the SNCA locus to identify RBD-specific risk variants.
Full sequencing and genotyping of SNCA was performed in isolated/idiopathic RBD (iRBD, n = 1,076), Parkinson disease (PD, n = 1,013), dementia with Lewy bodies (DLB, n = 415), and control subjects (n = 6,155). The iRBD cases were diagnosed with RBD prior to neurodegeneration, although some have since converted. A replication cohort from 23andMe of PD patients with probable RBD (pRBD) was also analyzed (n = 1,782 cases; n = 131,250 controls). Adjusted logistic regression models and meta-analyses were performed. Effects on conversion rate were analyzed in 432 RBD patients with available data using Kaplan-Meier survival analysis.
A 5'-region SNCA variant (rs10005233) was associated with iRBD (odds ratio [OR] = 1.43, p = 1.1E-08), which was replicated in pRBD. This variant is in linkage disequilibrium (LD) with other 5' risk variants across the different synucleinopathies. An independent iRBD-specific suggestive association (rs11732740) was detected at the 3' of SNCA (OR = 1.32, p = 4.7E-04, not statistically significant after Bonferroni correction). Homozygous carriers of both iRBD-specific SNPs were at highly increased risk for iRBD (OR = 5.74, p = 2E-06). The known top PD-associated variant (3' variant rs356182) had an opposite direction of effect in iRBD compared to PD.
There is a distinct pattern of association at the SNCA locus in RBD as compared to PD, with an opposite direction of effect at the 3' of SNCA. Several 5' SNCA variants are associated with iRBD and with pRBD in overt synucleinopathies. ANN NEUROL 2020;87:584-598.
快速眼动睡眠行为障碍(RBD)是一种前驱性突触核蛋白病,超过 80%的患者最终会转化为显性突触核蛋白病。我们对 SNCA 基因座进行了深入分析,以确定 RBD 特异性风险变异。
对孤立性/特发性 RBD(iRBD,n=1076)、帕金森病(PD,n=1013)、路易体痴呆(DLB,n=415)和对照组(n=6155)进行了 SNCA 全长测序和基因分型。这些 iRBD 病例在神经退行性变前被诊断为 RBD,尽管有些病例后来已经转化。还分析了 23andMe 中具有可能的 RBD(pRBD)的 PD 患者的复制队列(n=1782 例;n=131250 例对照)。使用调整后的逻辑回归模型和荟萃分析进行了分析。对 432 名具有可用数据的 RBD 患者进行了生存分析,以分析对转化率的影响。
SNCA 基因的 5' 区变异(rs10005233)与 iRBD 相关(比值比[OR]为 1.43,p=1.1E-08),这在 pRBD 中得到了复制。该变异与不同突触核蛋白病中的其他 5' 风险变异处于连锁不平衡(LD)状态。在 SNCA 的 3' 处检测到一个独立的 iRBD 特异性提示关联(rs11732740)(OR=1.32,p=4.7E-04,经 Bonferroni 校正后无统计学意义)。这两个 iRBD 特异性 SNP 的纯合子携带者患 iRBD 的风险显著增加(OR=5.74,p=2E-06)。已知与 PD 相关的最高风险变异(3' 变异 rs356182)在 iRBD 中与 PD 的作用方向相反。
与 PD 相比,RBD 中 SNCA 基因座存在明显的关联模式,在 SNCA 的 3' 处作用方向相反。几个 5' SNCA 变异与 iRBD 相关,与显性突触核蛋白病中的 pRBD 相关。